To delineate CD44 and CD133 expression in the DLD-1 CRC cell line, we used flow cytometry to measure the expression of these surface molecules after double-staining with anti-CD44-FITC and anti-CD133-PE antibodies. Here, PROM1 is linked to colorectal carcinoma.